Trial intelligence / Profile preview

Pregabalin CR for postherpetic neuralgia

2009-016766-86Phase 3Terminated

Sponsor
Pfizer
Start
Dec 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in postherpetic neuralgia (PHN) comparing Pregabalin CR continuation with Placebo (2 arms). Started Dec 2010; status: terminated.

02

Drugs

pregabalin
03

Conditions

postherpetic neuralgia (PHN)

Beyond the preview

Go deeper on 2009-016766-86.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-016766-86.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call